| For: | Parfieniuk A, Flisiak R. Role of cannabinoids in chronic liver diseases. World J Gastroenterol 2008; 14(40): 6109-6114 [PMID: 18985799 DOI: 10.3748/wjg.14.6109] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i40/6109.htm |
| Number | Citing Articles |
| 1 |
Joseph B. Miller, Mark Walsh, Pankaj A. Patel, Michael Rogan, Cliff Arnold, Megan Maloney, Michael Donnino. Pediatric Cannabinoid Hyperemesis. Pediatric Emergency Care 2010; 26(12) doi: 10.1097/PEC.0b013e3181fe9189
|
| 2 |
Anna Maria Malfitano, Elena Ciaglia, Giuseppina Gangemi, Patrizia Gazzerro, Chiara Laezza, Maurizio Bifulco. Update on the endocannabinoid system as an anticancer target. Expert Opinion on Therapeutic Targets 2011; 15(3) doi: 10.1517/14728222.2011.553606
|
| 3 |
Rebekah Nash, Eric Golden, Mary Amanda Dew, Andrea F. DiMartini. Psychosocial Care of End-Stage Organ Disease and Transplant Patients. 2019; doi: 10.1007/978-3-319-94914-7_12
|
| 4 |
Botros Shenoda, Joseph Boselli. Vascular syndromes in liver cirrhosis. Clinical Journal of Gastroenterology 2019; 12(5) doi: 10.1007/s12328-019-00956-0
|
| 5 |
Carmen M. Mitchell, Omar El Jordi, Bryan K. Yamamoto. Role of Inflammation in Environmental Neurotoxicity. Advances in Neurotoxicology 2019; 3 doi: 10.1016/bs.ant.2018.10.006
|
| 6 |
Daniel Fuster, Xavier García-Calvo, Ferran Bolao, Paola Zuluaga, Gemma Rocamora, Anna Hernández-Rubio, Arantza Sanvisens, Jordi Tor, Robert Muga. Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment. Drug and Alcohol Dependence 2020; 216 doi: 10.1016/j.drugalcdep.2020.108231
|
| 7 |
Yu-Jin Kwon, Ji-Hye Kim, Dong-Hyuk Jung. Association Between Nonalcoholic Fatty Liver Disease and Intraocular Pressure in Korean Adults. Journal of Glaucoma 2018; 27(12) doi: 10.1097/IJG.0000000000001036
|
| 8 |
Munechika Enjoji, Motoyuki Kohjima, Kazuhiro Kotoh, Makoto Nakamuta. Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments. International Journal of Hepatology 2012; 2012 doi: 10.1155/2012/264017
|
| 9 |
|
| 10 |
Hedyeh Ebrahimi, Mohammadreza Naderian, Amir Ali Sohrabpour. New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article. Middle East Journal of Digestive Diseases 2018; 10(3) doi: 10.15171/mejdd.2018.103
|
| 11 |
David van der Poorten, Mahsa Shahidi, Enoch Tay, Jayshree Sesha, Kayla Tran, Duncan McLeod, Jane S. Milliken, Vikki Ho, Lionel W. Hebbard, Mark W. Douglas, Jacob George, Jean-Pierre Vartanian. Hepatitis C Virus Induces the Cannabinoid Receptor 1. PLoS ONE 2010; 5(9) doi: 10.1371/journal.pone.0012841
|
| 12 |
Epifania Balistreri, Estrella Garcia-Gonzalez, Enrico Selvi, Alfiya Akhmetshina, Katrin Palumbo, Sauro Lorenzini, Roberta Maggio, Monica Lucattelli, Mauro Galeazzi, Jörg W H Distler. The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model. Annals of the Rheumatic Diseases 2011; 70(4) doi: 10.1136/ard.2010.137539
|
| 13 |
Li-Jie Sun, Jian-Wu Yu, Lin Wan, Xiao-Yu Zhang, Yu-Guang Shi, Mo-Yang Chen. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication. International Journal of Infectious Diseases 2014; 23 doi: 10.1016/j.ijid.2013.12.017
|
| 14 |
Eleonora Patsenker, Matthias Stoll, Gunda Millonig, Abbas Agaimy, Till Wissniowski, Vreni Schneider, Sebastian Mueller, Rudolf Brenneisen, Helmut K. Seitz, Matthias Ocker, Felix Stickel. Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis. Molecular Medicine 2011; 17(11-12) doi: 10.2119/molmed.2011.00149
|
| 15 |
Susanne Oesch, Jürg Gertsch. Cannabinoid receptor ligands as potential anticancer agents — high hopes for new therapies?. Journal of Pharmacy and Pharmacology 2009; 61(7) doi: 10.1211/jpp.61.07.0002
|
| 16 |
Byeong-Ryeol Ryu, Min-Jun Kim, Min-Ji Kang, Chaylen Douglas Richards, Tae-Hyung Kwon, Sang-Hyuck Park, Jung-Dae Lim. Biochemical responses and endpoint RNA-seq level profiling of Cannabis sativa L. cv. Pink Pepper under heat stress. Plant Stress 2026; 23 doi: 10.1016/j.stress.2026.101490
|
| 17 |
Nazar Pryimak, Mariia Zaiachuk, Olga Kovalchuk, Igor Kovalchuk. The Potential Use of Cannabis in Tissue Fibrosis. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.715380
|
| 18 |
Laurence Brunet, Erica E. M. Moodie, Kathleen Rollet, Curtis Cooper, Sharon Walmsley, Martin Potter, Marina B. Klein. Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis. Clinical Infectious Diseases 2013; 57(5) doi: 10.1093/cid/cit378
|
| 19 |
Cecilia J. Sorensen, Kristen DeSanto, Laura Borgelt, Kristina T. Phillips, Andrew A. Monte. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review. Journal of Medical Toxicology 2017; 13(1) doi: 10.1007/s13181-016-0595-z
|
| 20 |
|
| 21 |
Eleonora Patsenker, Philip Sachse, Andrea Chicca, María Gachet, Vreni Schneider, Johan Mattsson, Christian Lanz, Mathias Worni, Andrea De Gottardi, Mariam Semmo, Jochen Hampe, Clemens Schafmayer, Rudolf Brenneisen, Jürg Gertsch, Felix Stickel, Nasser Semmo. Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation. International Journal of Molecular Sciences 2015; 16(4) doi: 10.3390/ijms16047057
|
| 22 |
Ahmed ElTelbany, George Khoudari, Yasser Al-Khadra, Arthur McCullough, Naim Alkhouri. Lower Rates of Hepatocellular Carcinoma Observed Among Cannabis Users: A Population-Based Study. Cureus 2022; doi: 10.7759/cureus.24576
|
| 23 |
Appendix C: References (Part I). Journal of Nursing Regulation 2018; 9(2) doi: 10.1016/S2155-8256(18)30100-5
|
| 24 |
|
| 25 |
Leontina-Elena Filipiuc, Raluca Ştefănescu, Carmen Solcan, Mitică Ciorpac, Andrei Szilagyi, Dana Cojocaru, Gabriela Dumitrita Stanciu, Ioana Creangă, Cătălin-Cezar Caratașu, Daniela-Carmen Ababei, Roxana-Elena Gavrila, Andrei-Daniel Timofte, Silviu-Iulian Filipiuc, Veronica Bild. Acute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified Cannabis sativa L. in Rodents. Pharmaceuticals 2023; 16(5) doi: 10.3390/ph16050694
|
| 26 |
Siwei Tan, Huiling Liu, Bilun Ke, Jie Jiang, Bin Wu. The peripheral CB1 receptor antagonist JD5037 attenuates liver fibrosis via a CB1 receptor/β‐arrestin1/Akt pathway. British Journal of Pharmacology 2020; 177(12) doi: 10.1111/bph.15010
|
| 27 |
Pratima Dibba, Andrew A. Li, George Cholankeril, Umair Iqbal, Chiranjeevi Gadiparthi, Muhammad Ali Khan, Donghee Kim, Aijaz Ahmed. The Role of Cannabinoids in the Setting of Cirrhosis. Medicines 2018; 5(2) doi: 10.3390/medicines5020052
|
| 28 |
Hemant Goyal, M. Rubayat Rahman, Abhilash Perisetti, Nihar Shah, Rajiv Chhabra. Cannabis in liver disorders: a friend or a foe?. European Journal of Gastroenterology & Hepatology 2018; 30(11) doi: 10.1097/MEG.0000000000001256
|
| 29 |
|
| 30 |
P. P. Basu, M. M. Aloysius, N. J. Shah, R. S. Brown Jr. Review article: the endocannabinoid system in liver disease, a potential therapeutic target. Alimentary Pharmacology & Therapeutics 2014; 39(8) doi: 10.1111/apt.12673
|
| 31 |
Part I: Current Legislation, Scientific Literature Review, and Nursing Implications. Journal of Nursing Regulation 2018; 9(2) doi: 10.1016/S2155-8256(18)30083-8
|
| 32 |
Ismail Maulood. Hemodynamic ,thyroid and immunomodulater effects of cannabinoid in rats.. Journal of Zankoy Sulaimani - Part A 2016; 18(2) doi: 10.17656/jzs.10505
|
| 33 |
Kathleen A. Russell. Caring for Patients Using Medical Marijuana. Journal of Nursing Regulation 2019; 10(3) doi: 10.1016/S2155-8256(19)30148-6
|
| 34 |
Eric Mensah, Reza Tabrizchi, Noriko Daneshtalab. Pharmacognosy and Effects of Cannabinoids in the Vascular System. ACS Pharmacology & Translational Science 2022; 5(11) doi: 10.1021/acsptsci.2c00141
|
| 35 |
Butros Fakhoury, Vinay Jahagirdar, Kaanthi Rama, David Hudson, Wei Wang, Luis Antonio Díaz, Juan Pablo Arab. The Cannabinoid System as a Potential Novel Target for Alcohol‐Associated Liver Disease: A Propensity‐Matched Cohort Study. Liver International 2025; 45(11) doi: 10.1111/liv.70401
|
| 36 |
Yan Wei, Xiao-li Kang, Xu Wang. The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression. Experimental Biology and Medicine 2014; 239(2) doi: 10.1177/1535370213514922
|
| 37 |
Julie Zhu, Kevork M Peltekian. Cannabis and the liver: Things you wanted to know but were afraid to ask. Canadian Liver Journal 2019; 2(3) doi: 10.3138/canlivj.2018-0023
|
| 38 |
Yosefa Avraham, Johnny Amer, Sarit Doron, Lina Abu-Tair, Mahmud Mahamid, Areej Khatib, Elliot M. Berry, Rifaat Safadi. The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 302(12) doi: 10.1152/ajpgi.00191.2011
|
| 39 |
Ralph-Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, Mohammad-Ali Jenabian, Cecilia T. Costiniuk. Cannabinoids and Chronic Liver Diseases. International Journal of Molecular Sciences 2022; 23(16) doi: 10.3390/ijms23169423
|
| 40 |
Wei Chen, Zhenhua Chen, Nina Xue, Zhibing Zheng, Song Li, LiLi Wang. Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 2013; 386(8) doi: 10.1007/s00210-013-0875-y
|
| 41 |
Part I: Current Legislation, Scientific Literature Review, and Nursing Implications. Journal of Nursing Regulation 2018; 9(2) doi: 10.1016/S2155-8256(18)30083-8
|
| 42 |
Matthew Flick, Casey Martinez, David C. Fipps, Erik Jönsson. Rastafarianism: When Religious Beliefs Conflict With Medical Necessity—A Case Report and Review of the Literature Around an Ethically Complicated Case. Case Reports in Psychiatry 2025; 2025(1) doi: 10.1155/crps/6621450
|
| 43 |
Puneet Puri, Arun J. Sanyal. Zakim and Boyer's Hepatology. 2012; doi: 10.1016/B978-1-4377-0881-3.00053-X
|
| 44 |
Samar Rezq, Reham Hassan, Mona F. Mahmoud. Rimonabant ameliorates hepatic ischemia/reperfusion injury in rats: Involvement of autophagy via modulating ERK- and PI3K/AKT-mTOR pathways. International Immunopharmacology 2021; 100 doi: 10.1016/j.intimp.2021.108140
|
| 45 |
Massimo Pinzani, Jose Macias-Barragan. Update on the pathophysiology of liver fibrosis. Expert Review of Gastroenterology & Hepatology 2010; 4(4) doi: 10.1586/egh.10.47
|
| 46 |
Xingpeng Di, Ya Li, Jingwen Wei, Tianyue Li, Banghua Liao. Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies. Advanced Science 2025; 12(3) doi: 10.1002/advs.202410416
|
| 47 |
Madeline Manning Meurer, Kalyan Chakrala, Dinesh Gowda, Charles Burns, Randall Kelly, Natalia Schlabritz-Loutsevitch. A Case of Cannabinoid Hyperemesis Syndrome with Heliobacter Pylori and Preeclampsia during Pregnancy. Substance Abuse 2018; 39(1) doi: 10.1080/08897077.2017.1356790
|
| 48 |
. 2018; doi: 10.70675/f7adebd1z4d68z4e22zbba9z0a29d133bf75
|
| 49 |
Sara Manti, Lucia Marseglia, Gabriella D Angelo, Martina Filippelli, Caterina Cuppari, Eloisa Gitto, Claudio Romano, Teresa Arrigo, Carmelo Salpietro. Portal Hypertension as Immune Mediate Disease. Hepatitis Monthly 2014; 14(5) doi: 10.5812/hepatmon.18625
|
| 50 |
Jingru Han, Yang Zhao, Simeng Gao, Yan Zhang, Yida Wang, Jianfu Zhao. Global Contribution of Drug Use to Cirrhosis and Hepatocellular Carcinoma Worldwide From 1990 to 2021 and Projections to 2045. INQUIRY: The Journal of Health Care Organization, Provision, and Financing 2025; 62 doi: 10.1177/00469580251399106
|
| 51 |
Ayman Alzu’bi, Mazhar Salim Al Zoubi, Bahaa Al-Trad, Manal Isam AbuAlArjah, Malek Shehab, Hiba Alzoubi, Dima Albals, Gamal T. Abdelhady, Waseem El-Huneidi. Acute Hepatic Injury Associated with Acute Administration of Synthetic Cannabinoid XLR-11 in Mouse Animal Model. Toxics 2022; 10(11) doi: 10.3390/toxics10110668
|
| 52 |
P.N. Soares, R.A. Miranda, T.C. Peixoto, F.A.H. Caramez, D.S. Guarda, A.C. Manhães, E. de Oliveira, E.G. de Moura, P.C. Lisboa. Cigarette smoke during lactation in rat female progeny: Late effects on endocannabinoid and dopaminergic systems. Life Sciences 2019; 232 doi: 10.1016/j.lfs.2019.116575
|
| 53 |
Ayman Alzu’bi, Fatimah Almahasneh, Ramada Khasawneh, Ejlal Abu-El-Rub, Worood Bani Baker, Raed M. Al-Zoubi. The synthetic cannabinoids menace: a review of health risks and toxicity. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-023-01443-6
|